Literature DB >> 16617568

Actinomycotic inflammatory disease and misdiagnosis of ovarian cancer. A case report.

Jalid Sehouli1, Jens H Stupin, Ulrike Schlieper, Sherko Kuemmel, Wolfgang Henrich, C Denkert, M Dietel, Werner Lichtenegger.   

Abstract

Actinomycosis in the pelvic region is an uncommon diagnosis. This infection is caused by Actinomyces israelii, a gram-positive anerobic saprophyte bacterium that is a normal inhabitant of the upper intestinal tract in humans. Pelvic actinomycosis is difficult to diagnose pre-operatively and is diagnosed, in most cases, accidentally. Actinomycosis can mimic pelvic and abdominal malignancies. A case report of a 35-year-old female patient with a fixed pelvic mass is presented and the diagnosis and treatment of pelvic actinomycotic inflammatory disease in relation to ovarian cancer are discussed. Clinicians should be aware of this rare infection to spare women potential morbidity from excessive surgical procedures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617568

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Diagnostic dilemma posed by severe pelvic actinomycosis associated with prolonged use of copper intrauterine contraceptive device.

Authors:  Subhayu Bandyopadhyay; Sanjay Sinha; Patrick Fan Wui Chien; Dawn Fleming
Journal:  Clin Pract       Date:  2011-11-25

2.  Differentiating pelvic actinomycosis from advanced ovarian cancer: a report of two cases, management reflections and literature review.

Authors:  Alex Laios; Iryna Terekh; Hooman Soleymani Majd; Pubudu Pathiraja; Sanjiv Manek; Krishnayan Haldar
Journal:  Gynecol Oncol Res Pract       Date:  2014-12-10

3.  Massive paediatric cervicofacial actinomycoses masquerading as an ulcerative malignancy.

Authors:  Carlson-Babila Sama; Nicole Fouda Mbarga; Calvin Eta Oben; Jules A Mbarga; Elvis Kiloh Nfor; Fru F Angwafo Iii
Journal:  BMC Infect Dis       Date:  2016-08-15       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.